Nation’s drug overdose epidemic requires new policy focus
The nation’s overdose epidemic is being increasingly fueled by illicitly manufactured fentanyl, psychostimulants, heroin, cocaine and drug combinations.
AMA applauds FDA for requiring naloxone information on opioid labels
The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.
AMA report shows evolving, deadlier overdose epidemic
AMA cites need to remove barriers to evidence-based care for patients with pain or a substance use disorder.
How to reignite the fight against the nation’s opioid epidemic
The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.
In COVID-19 crisis, AMA’s powerful voice rings out to save lives
Learn about the AMA’s effective advocacy on critical issues such as access to PPE, telehealth, financial relief for doctors, health care inequities, and more.
AMA COVID-19 daily video update: Experts discuss the pandemic’s impact on the opioid epidemic
The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.
COVID-19 may be worsening opioid crisis, but states can take action
The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights